Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Advanced glycation end products: Sparking the development of diabetic vascular injury
A drug that powerfully alters GLP-1, GIP, and glucagon signaling could have effects on development that we simply do not understand yet
Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study)
,
Identification of type 2 diabetes subgroups through topological analysis of patient similarity
US$ 29.03
US$ 21.37
US$ 28.31
US$ 29.71
